Hanck D A, Makielski J C, Sheets M F
Department of Medicine, University of Chicago, Illinois 60637.
J Gen Physiol. 1994 Jan;103(1):19-43. doi: 10.1085/jgp.103.1.19.
The interaction of antiarrhythmic drugs with ion channels is often described within the context of the modulated receptor hypothesis, which explains the action of drugs by proposing that the binding site has a variable affinity for drugs, depending upon whether the channel is closed, open, or inactivated. Lack of direct evidence for altered gating of cardiac Na channels allowed for the suggestion of an alternative model for drug interaction with cardiac channels, which postulated a fixed affinity receptor with access limited by the conformation of the channel (guarded receptor hypothesis). We report measurement of the gating currents of Na channels in canine cardiac Purkinje cells in the absence and presence of QX-222, a quaternary derivative of lidocaine, applied intracellularly, and benzocaine, a neutral local anesthetic. These data demonstrate that the cardiac Na channel behaves as a modulated rather than a guarded receptor in that drug-bound channels gate with altered kinetics. In addition, the results suggest a new interpretation of the modulated receptor hypothesis whereby drug occupancy reduces the overall voltage-dependence of gating, preventing full movement of the voltage sensor.
抗心律失常药物与离子通道的相互作用通常在调制受体假说的背景下进行描述,该假说通过提出结合位点对药物具有可变亲和力来解释药物的作用,这取决于通道是关闭、开放还是失活。由于缺乏心脏钠通道门控改变的直接证据,有人提出了药物与心脏通道相互作用的另一种模型,即假定存在一个固定亲和力受体,其通道构象限制了其可及性(保护受体假说)。我们报告了在细胞内应用利多卡因的季铵衍生物QX - 222和中性局部麻醉剂苯佐卡因的情况下,测量犬心脏浦肯野细胞中钠通道的门控电流。这些数据表明,心脏钠通道表现为调制受体而非保护受体,因为药物结合的通道门控动力学发生改变。此外,结果提示了对调制受体假说的一种新解释,即药物占据减少了门控的整体电压依赖性,阻止了电压传感器的完全移动。